These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 8467281
1. Is there an effective therapy for chronic graft-versus-host disease? Schiller G, Gale RP. Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281 [No Abstract] [Full Text] [Related]
3. Titrating graft-versus-host disease: is it worth a try? Akpek G. Bone Marrow Transplant; 2006 Nov; 38(10):653-6. PubMed ID: 17006455 [Abstract] [Full Text] [Related]
4. The potential utility of statins as novel weapons against graft-versus-host disease. Namazi MR, Handjani F, Sodaifi M. Med Hypotheses; 2005 Nov; 65(6):1203-4. PubMed ID: 16139438 [No Abstract] [Full Text] [Related]
5. Factors influencing the risk of acute and chronic graft-versus-host disease in humans: a preliminary report from the IBMTR. Bortin MM, Atkinson K, van Bekkum DW, Biggs JC, Dicke KA, Gale RP, Gluckman E, Good RA, Hoffmann RG, Horowitz MM. Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():222-4. PubMed ID: 2653507 [No Abstract] [Full Text] [Related]
6. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Urban CH, Deutschmann A, Kerbl R, Lackner H, Schwinger W, Königsrainer A, Margreiter R. Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895 [Abstract] [Full Text] [Related]
12. [Allogenic bone marrow transplantation complications. Part II]. Saloua L, Tarek BO, Abderrahman A, Abdeladhim BA. Tunis Med; 2000 Mar 06; 78(3):152-7. PubMed ID: 11026816 [Abstract] [Full Text] [Related]
13. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases. Tolland JP, Devereux C, Jones FC, Bingham EA. Pediatr Dermatol; 2008 Mar 06; 25(2):240-4. PubMed ID: 18429789 [Abstract] [Full Text] [Related]
14. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)]. Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L. Zhonghua Xue Ye Xue Za Zhi; 2003 Aug 06; 24(8):416-9. PubMed ID: 14642179 [Abstract] [Full Text] [Related]